The Role of Vitamin D in Immune Function in Patients With CKD Stages 3 and 4.
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science
The primary endpoint will be the change in CD4+/CD8+ ratio and other flow cytometry parameters based on the results of Aims 1 and 2, TH1/TH2 cytokine profile, and conversion from anergic to reactive skin testing.
6 months from baseline visit
Sharon M Moe, MD
Indiana University School of Medicine
United States: Institutional Review Board
|Indiana University School of Medicine||Indianapolis, Indiana 46204|